At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jul 2, 2026 at 19:00 ET
Two Septerna insiders (SVP Drug Discovery and Chief People Officer) sold a combined $148K in open-market shares after exercising options. The sales represent ~0.009% of the $1.6B market cap, trivial and consistent with routine tax/vesting-related transactions. No material signal for the stock.
- Total open-market sales: $148K (0.009% of $1.6B market cap)
- Both sales occurred on the same day as option exercises (tax/vesting pattern)
- 7 directors received non-cash stock grants on 2026-06-26 (no economic value)
- Insider activity is routine and immaterial relative to company size
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access